EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Silencing of SCEL promotes progression of oral squamous cell carcinoma via activating TGF-β/Smad pathway

Danping Li, Limei Li, Shu Wu, Jun Zhao, Haishan Zhang, Qiaoli Chen, Yingxi Mo, Liudmila Matskova, Ping Li, Xiaoying Zhou

Discover Oncology · 15.05.2025 · 16 (1)

DOI: 10.1007/s12672-025-02423-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Discover Oncology, online erschienen am 15.05.2025. Verfasst von Danping Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, College & Hospital of Stomatology, Guangxi Medical University, #10 Shuangyong Road, Nanning, 530021, China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Guangxi Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: SCEL serves as a precursor protein for the cornified envelope (CE), and its abnormal expression has been identified in various malignancies. Despite this, the functional role and detailed mechanisms of SCEL in oral squamous cell carcinoma (OSCC) remain to be clarified. METHODS: mRNA and protein expression of SCEL in OSCC cell lines and patient tissues were examined by qRT-PCR and IHC. In vitro and in vivo experiments assessed SCEL's influence on proliferation, apoptosis, cell cycle, ROS production, migration, and invasion. Western blotting was used to analyze SCEL's effect on various signaling pathways, and a dual-luciferase reporter assay identified the miRNA that targets SCEL. RESULTS: SCEL is downregulated in OSCC, which correlates with reduced tumor cell differentiation and lymph node metastasis. SCEL inhibits OSCC proliferation, induces cell cycle arrest, apoptosis, and ROS production. SCEL suppresses the TGF-β/Smad pathway, inhibiting migration and invasion. SCEL also triggers MET and downregulates VEGFC, reducing lymph node metastasis probability. miR-5696 inhibitor effectively inhibits OSCC proliferation and invasion by targeting SCEL. CONCLUSION: SCEL acts as a tumor suppressor in OSCC, influencing its progression and potential metastasis. Loss of SCEL facilitates OSCC progression by activating TGF-β/Smad signaling. Upregulating SCEL and silencing miR-5696 hold therapeutic promise for OSCC.

Schlagwörter

Stichwörter der Autor:innen

DifferentiationMetastasisMiR-5696Oral squamous cell carcinomaSCELTGF-β signaling pathway

Autor:innen und Institutionen

  • Department of Pathology, College & Hospital of Stomatology, Guangxi Medical University, #10 Shuangyong Road, Nanning, 530021, China.
  • Ministry of Education, Key Laboratory of High-Incidence-Tumor Prevention & Treatment (Guangxi Medical University), Nanning, China.
  • Department of Pathology, Guangxi Medical University Cancer Hospital, Nanning, China.
  • Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, 17177, Stockholm, Sweden.
  • Institute of Molecular Biology and Biophysics of Federal Research Center of Fundamental and Translational Medicine (IMBB FRC FTM), 2/12, Timakova Street, 630117, Novosibirsk, Russia.
  • Department of Pathology, College & Hospital of Stomatology, Guangxi Medical University, #10 Shuangyong Road, Nanning, 530021, China. liping@gxmu.edu.cn.

Förderung

  • Guangxi Natural Science Foundation

Zitieren

APA

Li, D., Li, L., Wu, S., Zhao, J., Zhang, H., Chen, Q., Mo, Y., Matskova, L., Li, P., & Zhou, X. (2025). Silencing of SCEL promotes progression of oral squamous cell carcinoma via activating TGF-β/Smad pathway. Discover Oncology, 16(1). https://doi.org/10.1007/s12672-025-02423-4

Vancouver

Li D, Li L, Wu S, Zhao J, Zhang H, Chen Q, et al. Silencing of SCEL promotes progression of oral squamous cell carcinoma via activating TGF-β/Smad pathway. Discover Oncology. 2025;16(1). doi:10.1007/s12672-025-02423-4

BibTeX
@article{Li2025,
  author = {Li, Danping and Li, Limei and Wu, Shu and Zhao, Jun and Zhang, Haishan and Chen, Qiaoli and Mo, Yingxi and Matskova, Liudmila and Li, Ping and Zhou, Xiaoying},
  title = {Silencing of SCEL promotes progression of oral squamous cell carcinoma via activating TGF-β/Smad pathway},
  journal = {Discover Oncology},
  year = {2025},
  volume = {16},
  number = {1},
  doi = {10.1007/s12672-025-02423-4}
}
Kostenlos starten →